NEW YORK (GenomeWeb) – With the launch last week of its next-generation CyTOF platform, Helios, Fluidigm aims to up capabilities for existing users while drawing new customers into the fold with streamlined and simplified operations.

Notably, the new system features a new sample introduction system that allows for increased sample volumes and better sampling efficiency, Tad George, senior director of applications at Fluidigm, told GenomeWeb this week. It also provides a roughly 50 percent increase in sensitivity and increased multiplexing capabilities.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.

Sponsored by

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.